VanEck Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-179,488
Closed -$33M 1331
2021
Q2
$33M Buy
179,488
+4,396
+3% +$808K 0.08% 200
2021
Q1
$26.8M Sell
175,092
-24,714
-12% -$3.78M 0.07% 199
2020
Q4
$31.2M Buy
199,806
+13,215
+7% +$2.06M 0.09% 172
2020
Q3
$21.4M Sell
186,591
-1,691
-0.9% -$193K 0.07% 175
2020
Q2
$21.1M Buy
188,282
+20,058
+12% +$2.25M 0.07% 174
2020
Q1
$15.1M Buy
168,224
+20,862
+14% +$1.87M 0.08% 166
2019
Q4
$15.9M Buy
147,362
+10,960
+8% +$1.19M 0.06% 198
2019
Q3
$13.4M Buy
136,402
+5,437
+4% +$532K 0.06% 190
2019
Q2
$17.2M Sell
130,965
-8,081
-6% -$1.06M 0.08% 179
2019
Q1
$18.8M Sell
139,046
-15,165
-10% -$2.05M 0.09% 167
2018
Q4
$15M Sell
154,211
-20,379
-12% -$1.98M 0.08% 193
2018
Q3
$24.3M Buy
174,590
+22,645
+15% +$3.15M 0.12% 157
2018
Q2
$18.9M Sell
151,945
-20,111
-12% -$2.5M 0.09% 180
2018
Q1
$19.2M Sell
172,056
-66,585
-28% -$7.42M 0.1% 172
2017
Q4
$28.5M Buy
238,641
+14,222
+6% +$1.7M 0.14% 150
2017
Q3
$31.5M Sell
224,419
-59,707
-21% -$8.38M 0.16% 135
2017
Q2
$34.6M Buy
284,126
+40,408
+17% +$4.92M 0.19% 95
2017
Q1
$29.5M Buy
243,718
+39,075
+19% +$4.74M 0.13% 130
2016
Q4
$25M Sell
204,643
-10,750
-5% -$1.32M 0.12% 120
2016
Q3
$26.4M Buy
215,393
+40,759
+23% +$4.99M 0.12% 109
2016
Q2
$20.4M Buy
174,634
+12,422
+8% +$1.45M 0.1% 112
2016
Q1
$22.6M Sell
162,212
-22,164
-12% -$3.09M 0.15% 117
2015
Q4
$35.2M Sell
184,376
-6,587
-3% -$1.26M 0.28% 86
2015
Q3
$29.9M Sell
190,963
-72,678
-28% -$11.4M 0.23% 104
2015
Q2
$47.7M Buy
263,641
+70,595
+37% +$12.8M 0.28% 90
2015
Q1
$33.5M Buy
193,046
+25,361
+15% +$4.4M 0.19% 114
2014
Q4
$31M Buy
167,685
+3,306
+2% +$612K 0.19% 109
2014
Q3
$27.3M Buy
164,379
+16,272
+11% +$2.7M 0.14% 129
2014
Q2
$23.1M Sell
148,107
-31,533
-18% -$4.93M 0.11% 134
2014
Q1
$27.3M Sell
179,640
-4,723
-3% -$719K 0.14% 124
2013
Q4
$24.5M Sell
184,363
-3,006
-2% -$399K 0.12% 125
2013
Q3
$21.8M Buy
187,369
+29,451
+19% +$3.42M 0.11% 106
2013
Q2
$14.6M Buy
+157,918
New +$14.6M 0.08% 120